Go beyond detection to sustained lung cancer success.

An incidental lung finding is a call to action. Eon Lung translates identified disease into coordinated follow-up, sustained surveillance, and completed care.
Request a demo

Detection is straightforward. What comes after is hard to master.

The journey from finding to treatment takes time, collaboration, and most of all – care.

Identification is only the first step.

Lung findings are being surfaced at unprecedented scale across imaging. But identification alone does not ensure patients receive timely, appropriate follow-up.
50K radiology reports per year; 23K incidental findings per year; 4-15 min of validation per case; 3,833 hours per year = 1.9 full-time employees for validation alone based on 3,833 hours fully dedicated to data validation annually.

Data validation can’t scale without support.

Before care can move forward, teams must review findings, assess risk, and determine next steps. As volumes grow, this effort compounds and becomes harder to sustain.

Surveillance efforts have to adapt to complete needed care.

Long-term surveillance is complex and unpredictable. Patients require follow-up that unfolds over months or years, and delayed orders or scheduling, or new clinical evidence can disrupt care plans and risk later-stage diagnosis.

Eon’s unique AI model identifies every incidental finding with precision, enables smart validation, automates follow-up and catches cancers earlier, at scale without adding staff to your team.

Create a clearer pathway to achieving your lung care outcomes.

Find more cancers at Stage I, not Stage IV.
Detect disease
earlier
Ensure high-risk patients receive immediate intervention.
Drive adherence
Automate standardized follow-up workflows.
Reduce admin burden
Convert early detection into downstream care opportunities.
Care for more patients

Efficiently identify, track, and manage more patients – with the same team you have today.

Identify Patients
PRECISION IDENTIFICATION™

Clinical intelligence you can act on immediately

There’s data and there’s truth. While most AI extracts general findings, Eon’s disease-specific models deliver >99% precision across 50+ clinical markers, ensuring care teams can trust what they see and act with confidence.

Validate Data
SMART VALIDATION™

Turn AI from human supervision to trustworthy automation

Every clinical AI output requires human validation. Eon reduces the manual burden of this effort down to a fraction of the time, giving navigators hours back for patient care—not data review.

Determine Follow-up
INTELLIGENT CARE PLANS

Evidence-based follow-up recommendations, instantly delivered

Radiology reports aren’t roadmaps—nearly half of them omit a clear next step. When one is present, Eon incorporates it into the care plan. When it isn’t, Eon leverages validated findings to generate an evidence-based care plan that you can activate in one click.

Monitor Adherence
FOLLOW-UP LISTENER™

Dynamic follow-up that adapts to the unexpected

Most systems track what’s expected. Eon detects the unexpected—new imaging, evolving risk, stalled care—and automatically adapts the care plan to clinical circumstances, flagging the record for navigator action.

Drive Performance
EON INSIGHTS

Capture the insights that drive better care

Like incidental findings, critical data can be buried in reports or tracked in disparate ways across sites. Eon gives clinical, operational, and executive teams the visibility they need to measure program impact and support patient outcomes systemwide.

The tech to manage every nodule. The team to help bring patients back for care.

Eon's Care Management team helps manage lower-risk patients so your team can focus on complex, high-priority care.
Learn More

Health system leaders are transforming lung cancer outcomes with Eon.

"Since our Eon go-live, we've diagnosed 260 lung cancers just through early detection... and doubled the amount of Stage I and II cases in our system."

Emily Cassidy, MD, Thoracic Surgeon, Our Lady of the Lake

"Last fiscal year we identified roughly 7,100 incidental pulmonary nodules. With Eon, we're on track for almost 18,000 this year. Without Eon’s Care Management, we would be a broken system."

Parker Harris, CEO of Baptist Memorial Hospital-Tipton

70% of cancers diagnosed in Stage I or Stage II

FMOL Health | Our Lady of the Lake

Over 50% reduction in time-to-treatment

Lifepoint Health

$3.44M in new direct margin

Baptist Memorial Health Care

90% of cancer patients returned for in-network care

Virtua Health

147% reduction in time-to-recommended-next-step
(34 days to 5 days)

UCHealth

247% growth in thoracic oncology referrals

FMOL Health | Our Lady of the Lake

89% of incidental pulmonary nodule patients returned for follow-up

Baptist Memorial Health Care

4 months to break-even ROI

UCHealth

Eon drives screening efficiency so you can manage the incidentals you aren't today.

“We’ve found the time it takes to review lung cancer screening exam results and move patients into their care pathway has gone from approximately six minutes to about ninety seconds."


Cindy Lambdin, RN, MS Nurse Manager, Lung Cancer Screening, Henry Ford Health

Dive deeper into Eon's impact, innovation, and insights on lung care.

How Baptist Scaled Lung Outcomes Without Adding Headcount

Download now
Click here to read more

Five Lessons for Building a Scalable Lung Nodule Program

Download now
Click here to read more

How UCHealth Cut Time-to-Treatment and Hit 4-Month ROI

Download now
Click here to read more

Why "Low-Risk" Lung Nodules Need Surveillance

Read now
Click here to read more